-->

We thank you for your continued support.

Your donations and kind contributions are invaluable to continue our mission.

Your donations go directly to academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Thank you for your consideration. All contributions help. Donate Now.

We thank you for your continued support.

Your donations and kind contributions are invaluable to continue our mission.

Your donations go directly to academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness. Thank you for your consideration. All contributions help.

Public Statement May 12, 2021
FLCCC Alliance Statement on the Irregular Actions of Public Health Agencies and the Widespread Disinformation Campaign Against Ivermectin
Awareness of ivermectin’s efficacy and its adoption by physicians worldwide to successfully treat COVID-19 have grown exponentially over the past several months. Oddly, however, even as the clinical trials data and successful ivermectin treatment experiences continue to mount… Read Full Statement

Joint Statement May 03, 2021
Joint Statement on Widespread Use of Ivermectin in India for Prevention and Early Treatment
The Evidence-Based Medicine Consultancy Ltd (E-BMC Ltd) is a UK-based independent medical research company that contributes to the quality of healthcare globally through the rigorous evaluation of medical evidence to support clinical practice guidelines. Read Full Statement

Public Statement April 29, 2021
Front Line COVID-19 Critical Care Alliance Statement on New Guidance on Ivermectin from the All India Institute of Medical Science
WASHINGTON, D.C. – The Front Line COVID-19 Critical Care Alliance (FLCCC), a group of highly published, world-renowned critical care physicians and scholars, today praised the recent updated guidance from the All India Institute of Medical Science (AIIMS) to include ivermectin in its guidelines for the treatment of COVID-19. Read Full Statement

Only 8 hours after this COVID-19 patient took ivermectin, she snapped back to health (April 21, 2021) Read More

Please regard our Help pages – and also share the 20+ Translations of our COVID-19 protocols with your networks, friends and colleagues around the world!

WEBINAR
Weekly Update · Live · Every Wednesday · 7 pm ET
Dr. Pierre Kory, FLCCC President & Chief Medical Officer, joins host Betsy Ashton, FLCCC Creative Director, every Wednesday to feature the latest information about our MATH+ and I-MASK+ protocols, status updates about the pandemic, emerging COVlD-19 therapeutics—and YOUR questions.

REGISTER HERE WATCH ARCHIVED WEEKLY UPDATES

These Brave Doctors are Upholding Their Hippocratic Oath & Putting Patients—Not Profits—First (April 19, 2021) Read More


Press Release April 9, 2021
 Front Line COVID-19 Critical Care Alliance Statement on Recent Washington Post Story
WASHINGTON, D.C. – We appreciate the interest from the Washington Post in the use of ivermectin as a safe and effective preventative and treatment for COVID-19. However, the article published yesterday left out several key components of the complete story of how ivermectin is saving lives all over the world. These include the overwhelming amount of data on ivermectin… Read full release

Article April 7, 2021
Expanding Our Strategy to End The Pandemic
Dr. Pierre Kory and Dr. Colleen Aldous write that the World Health Organization and National Institutes of Health now have all the data they need to recommend ivermectin to prevent and treat COVID-19—and put an end to the pandemic.

Check out the new FLCCC Support Store

We are excited to announce that we have opened an online store where you can help to support our lifesaving mission just by purchasing our specially branded merchandise.

www.theflcccstore.org

Our work to save as many lives as we possible can is urgent—both in the United States and across the world. But it requires that we secure enough revenue for the FLCCC—a 501(c)3 charitable organization—to continue implementation and promotion of our bold, global initiatives. All funds received through purchases will go directly towards fulfillment of our resolve to end this pandemic and save every life we can. Thank you!

Review Article April 5, 2021
 Global trends in clinical studies of ivermectin in COVID-19
Dr. Satoshi Ōmura, co-author of the newly published paper, “Global trends in clinical studies of ivermectin in COVID-19” was one of the four researchers from Kitasato University in Tokyo, Japan who received the Nobel Prize in Physiology or Medicine in 2015 for their discovery of ivermectin. Read More

Public Statement April 03, 2021

FLCCC Alliance Response to All National and International Health Agency Recommendations Against Ivermectin in COVID-19

Despite the rapidly increasing and diverse amounts of medical evidence supporting ivermectin as a life-saving therapy in COVID, multiple national and international health agencies.

Public Statement March 31, 2021
 FLCCC Alliance Statement on Weak Guidance on Ivermectin from the WHO
WHO ignores significant data, including several large clinical trials, while claiming insufficient evidence to recommend the use of ivermectin to prevent and treat COVID-19. Read our answer.

Global Medical & Scientific Experts Call Upon World Governments to Act Now to Save Lives (March 18, 2021)  Read More

Please also review our Release on EIN Presswire

Public Statement March 10, 2021
Censorship Kills: The Shunning of a COVID Therapeutic
A commentary on RealClearPolitics by Pierre Kory

Press Release March 9, 2021
 FLCCC Alliance Applauds International Group of Medical Experts’ Recognition of Ivermectin as a Safe and Effective Treatment for COVID-19
UK-based panel of leading experts publish their review of the latest research and call for the immediate global adoption of ivermectin to prevent and treat COVID-19 –  e-bmc.co.uk.

WEBINAR Jan 29, 2021
 Ivermectin and COVID-19: A YPO Gold International Webinar with the FLCCC Alliance
Dr. Pierre Kory’s lecture and slide presentation on January 27, 2021, hosted by YPO Gold’s Southern California Chapter for hundreds of CEOs within the international YPO network.

NIH (National Institutes of Health) Revises Treatment Guidelines for Ivermectin for the Treatment of COVID-19

Ivermectin is Now a Treatment Option for Health Care Providers!

Jan 14, 2021 – One week after Dr. Paul Marik and Dr. Pierre Kory – founding members of the Front Line COVID-19 Critical Care Alliance (FLCCC) – along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH has upgraded their recommen­da­tion and now considers ivermectin an option for use in COVID-19.   Read More

Read our  Press Release (Jan 15) and our  Detailed response to the panel’s criticism of the existing evidence base (Jan 17).

“The I-MASK+ protocol will revolutionize the treatment of COVID-19”

Dr. Paul Marik (Oct. 30, 2020)

The Front Line COVID-19 Critical Care Alliance has now developed a preventive and early outpatient combination treatment protocol for COVID-19 called I-MASK+. The “I” in this protocol for ivermectin, a well-known anti-parasite drug. Ivermectin has recently discovered anti-viral and anti-inflammatory properties and a rapidly growing published medical evidence base demonstrating its unique and highly potent ability to inhibit SARS-CoV-2 replication.

Please visit these links to get the full picture:

In March, 2020 we first published our  MATH+ Treatment Protocol for COVID-19, intended for hospitalized patients. The recently developed  I-MASK+ Prevention & Early Outpatient Treatment Protocol for COVID-19 is instead directed for use as a prevention and in early outpatient treatment after contracting COVID-19. The protocols thus complement each other, and both are physiologic-based combination treatment regimens developed by leaders in critical care medicine. All component medicines are FDA-approved (except ivermectin), inexpensive, readily available and have been used for decades with well-established safety profiles.

.

ESSENTIAL DOCUMENTS

 A Clinical Guide to the Care of the COVID-19 Patient. By Dr. Paul E. Marik, FLCCC Alliance (updated April 29, 2021)

 Ivermectin in the prevention and treatment of COVID-19
A comprehensive FLCCC Alliance review. Quick reference:  One-page Summary

MORE NEWS & UPDATES

Apr 13, 2021  [ResearchSquare]
New PSM retrospective study: Thiamine (vitamin B1) – part of our MATH+ protocol for COVID-19 since March 2020 – halves mortality of ICU patients, and a thrombosis risk divided by 5

Apr 6, 2021  [AfriForum]
A settlement regarding ivermectin is now an order of the South African court. IVM can now be used for COVID-19 in SA!

Mar 22, 2021  [UK]
The British Pharmacy Magazine: Ivermectin for COVID-19: A cheap drug with a remarkable effect

Mar 10, 2021  [medium.com]
Merck, It’s Truth-telling Time. – A plea by Joyce Kamen (FLCCC)

Mar 5, 2021  [France]
Covid-19: MedinCell publishes an extensive  Ivermectin Safety Expert Analysis (full report)

Mar 5, 2021  [Europe]
Ivermectin is now in official COVID-19 use in 2 European countries:  Czech Republic and  Slovakia.

Feb 26, 2021  [EBMC]
The British Ivermectin Recom­menda­tion Develop­ment (BIRD) Webinar on the Use of Iver­mectin for Covid-19:  Executive Summary on the meeting on Feb 20. Watch the recording on Youtube.

Feb 25, 2021  [mediapart.fr]
 Why Ivermectin is probably the best treatment for Covid, by Gérard Maudrux, MD

Feb 15, 2021  [論座]
Ivermectin discovered by Dr. Omura may end the corona pandemic. Article in the Japanese magazine ‘Ronza’.

Feb 11, 2021  [Elsevier]
Alliance Member Juan Chamie et al posts epidemiologic paper proving efficacy of ivermectin in controlling pandemic throughout Peru:  Sharp Reductions in COVID-19 Case Fatalities and Excess Deaths in Peru in Close Time Conjunction, State-By-State, with Ivermectin Treatments

February 8, 2021—On “The Doctors” TV program, Dr. Pierre Kory presented medical evidence about ivermectin’s efficacy in the prevention and treatment of COVID-19. More information for viewers and the recording can be found here.

Feb 4, 2021  [Hospital Pharmacy Europe]
‘Failure to act swiftly on this evidence might begin to look like dereliction of moral responsibility.’  Ivermectin – time for action

Feb 2, 2021  [Buffalo News]
The top story in the Buffalo News in February 2, 2021:  Doctors finding success using ivermectin.

Jan 19, 2021  [@DrAndrewHill]
‘Millions of vaccine doses were manufactured “at risk” before efficacy was confirmed — Can we do the start to upscale ivermerctin production as well?’    Dr. Hill’s meta analysis

Jan 14, 2021  [Hugh Hewitt Show]
Dr. Kory speaks to millions on Hugh Hewitt show on the therapeutic value of ivermectin in treatment of COVID-19.

Jan 3, 2021  [EBMC]
Highly respected independent research group produces a  Rapid review and meta-analysis of the recommendation of the FLCCC Alliance on ivermectin, and calls for immediate use of ivermectin in treating COVID-19.

Ivermectin & COVID-19

Dr. Pierre Kory testifies to Senate Committee about ivermectin, Dec. 8, 2020   Read More

external

Source: Database of all ivermectin COVID-19 studies
c19ivermectin.com (constantly updated)

external

Source: Global ivermectin adoption for COVID-19
ivmstatus.com (constantly updated)

How the FLCCC Alliance came together and developed effective treatment protocols for COVID-19  Read More

The FLCCC Alliance

As a group of colleagues with over 200 years of combined experience in Critical Care and Emergency Medicine, as well as long-standing shared interests in developing effective treatments for critical illnesses including sepsis, we, the  FLCCC Alliance, formed a working group devoted to creating a treatment protocol against COVID-19 in early March 2020. The protocol we devised, called  MATH+, is intended for use in hospitalized patients, with an emphasis on early initiation—as soon as a patient develops the need for supplemental oxygen.

The success of the MATH+ hospital treatment protocol is detailed in the team’s  Clinical and Scientific Rationale for the MATH+ Hospital Treatment Protocol for COVID-19 published in the Journal of Intensive Care Medicine in December 2020. The two hospitals that adopted the MATH+ protocol and initiated it early in the treatment of COVID-19 patients (in ICU) averaged only a 5.1% mortality rate, compared with mortality rates reported from other hospitals of between 10–30% during the same time periods, depending on whether corticosteroids were used.

Since October 2020 we regard ivermectin as a core medication in the prophylaxis and treatment of COVID-19. The rationale for this can be found in our  Review of the Emerging Evidence Supporting the Use of Ivermectin in the Prophylaxis and Treatment of COVID-19.

Information about the team’s more recent protocol for prevention and early outpatient treatment of COVID-19 can be found on our I-MASK+ protocol page.

The FLCCC Alliance – On a Mission to Save Thousands & Slow the Pandemic   Read More

PLEASE DONATE TO SUPPORT OUR MISSION! The FLCCC needs your support to continue and expand its efforts to share the latest information on effective treatments of COVID-19 patients while the vaccine is being distributed. Your donations will help support the FLCCC Alliance with the rising costs of public relations, research, medical translation and advocacy. The FLCCC Alliance has been incorporated in the State of Delaware and received 501(c)3 federal tax-exempt status as a public charity. You will find our Mission Statement and Objectives on About the FLCCC Alliance.

Image: Dr. Joseph Varon (FLCCC Alliance) visits a patient during rounds in his COVID-19 unit at United Memorial Medical Center, Houston, TX, USA. July 6, 2020. Photo: © 2020 David J. Phillip – AP/PA

What can you do to prevent getting COVID-19?   Read More

We would like to emphasize that the FLCCC Alliance is not opposed to vaccination, and furthermore supports policies such as mask wearing, social distancing, and hand hygiene to prevent the further spread of the SARS-CoV-2 virus. Our treatment proposals are designed, first of all, to mitigate the effects of the pandemic until it is overcome, and to allow for an earlier return to daily life.